Rhea-AI Summary
Lycia Therapeutics (LYCA) closed its upsized initial public offering, raising approximately $365.1 million in gross proceeds before offering costs.
The company sold 20,286,000 common shares at $18.00 per share, including 2,646,000 additional shares purchased through the underwriters’ full exercise of their option. All shares were offered by Lycia. Gross proceeds exclude underwriting discounts and commissions and other offering expenses. The shares began trading on the Nasdaq Global Select Market on October 23, 2026, under the symbol LYCA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of Lycia Therapeutics (LYCA)?
Lycia Therapeutics (LYCA) last closed at $28.85.
What is the market cap of Lycia Therapeutics (LYCA)?
The market cap of Lycia Therapeutics (LYCA) is approximately $1.6B.